Filing Details

Accession Number:
0001593968-21-000530
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-17 21:36:47
Reporting Period:
2021-02-16
Accepted Time:
2021-02-17 21:36:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1673772 Rapt Therapeutics Inc. RAPT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1635616 G. Dirk Brockstedt C/O Rapt Therapeutics, Inc.,
561 Eccles Avenue
South San Francisco CA 94080
Chief Scientific Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-16 8,245 $6.30 28,057 No 4 M Direct
Common Stock Acquisiton 2021-02-16 1,632 $6.18 29,689 No 4 M Direct
Common Stock Disposition 2021-02-16 9,877 $21.22 19,812 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2021-02-16 1,632 $0.00 1,632 $6.18
Common Stock Option (right to buy) Disposition 2021-02-16 8,245 $0.00 8,245 $6.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,403 2028-03-27 No 4 M Direct
5,906 2029-03-27 No 4 M Direct
Footnotes
  1. Includes 2,256 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on May 1, 2020.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.